Inflammation at the Nexus of Neurodegeneration: Cellular Mechanisms, Biomarkers and Therapeutic Targets
A Special Issue of Cells (ISSN 2073-4409) belonging to the section "Cellular Neuroscience".
Deadline for manuscript submissions: 15 December 2026 | Viewed by 1777
Editor
Special Issue Information
Dear Colleagues,
Neuroinflammation is increasingly recognised as a central driver, rather than a mere bystander, in diverse neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, retinal degeneration and rare inherited disorders. This Special Issue will highlight cellular and molecular inflammatory mechanisms that shape neuronal vulnerability and resilience, with a particular focus on microglia, astrocytes, peripheral immune cells, and the neurovascular unit. We welcome original research and reviews spanning innate and adaptive immune signaling; inflammasomes and cytokine networks; complement and chemokine pathways; crosstalk between metabolism, mitochondrial stress and inflammation; cell death pathways linked to inflammatory signaling; and the development of inflammatory biomarkers from tissue, CSF, blood and imaging. Studies employing cutting-edge approaches, including single‑cell and spatial-omics, advanced imaging, human stem‑cell or organoid models, and translational or interventional studies, are particularly encouraged. By integrating mechanistic, translational and clinical perspectives, this Special Issue aims to define how targeting inflammation can modify disease course and inform next‑generation neuroprotective therapies.
Dr. Kirstan A. Vessey
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroinflammation
- microglia
- astrocytes
- neurovascular unit
- inflammasome
- cytokine signaling
- cell death pathways
- biomarkers
- retinal degeneration
- neurodegenerative disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
